Date Filed | Type | Description |
08/10/2023 |
8-K
| Quarterly results |
08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/08/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
07/11/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
06/28/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
06/02/2023 |
SC 13G
| Klunzinger Jeffrey R. reports a 5.2% stake in Monopar Therapeutics Inc. |
06/01/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
05/11/2023 |
8-K
| Quarterly results |
05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
04/28/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/27/2023 |
8-K
| Quarterly results |
03/23/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/23/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
02/27/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
02/14/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
01/26/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
01/18/2023 |
8-K
| Quarterly results |
01/05/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
01/04/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
12/21/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
12/12/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
11/16/2022 |
8-K
| Quarterly results |
11/10/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
11/10/2022 |
8-K
| Quarterly results |
10/05/2022 |
8-K
| Quarterly results |
08/12/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
08/11/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
08/11/2022 |
8-K
| Quarterly results |
06/30/2022 |
8-K
| Quarterly results |
05/12/2022 |
8-K
| Quarterly results |
05/12/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
04/29/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
|